Breaking Down the U.S. Global Health Budget by Program Area

Published: Apr 21, 2026

Overview

This fact sheet provides a historical overview of U.S. funding for global health by program area over the past decade. Funding totals are based on amounts specified by Congress in annual appropriations bills, as well as some amounts that are determined at the agency level. Since the beginning of the second Trump administration, the U.S. global health response has undergone significant change, including a restructuring of how foreign assistance is provided, elimination of the U.S. Agency for International Development (USAID), the main implementing agency for U.S. global health efforts, and cancellation of most awards to organizations implementing programs. The full impact of these changes to foreign assistance, including whether all the funding appropriated by Congress for global health will be fully spent by the administration, is not yet clear. See our Budget Tracker for more detail on historical funding, Budget Summaries for the latest on ongoing appropriations discussions, and Country-Level Funding Tracker for detail on country-specific appropriated (planned) funding, obligations, and disbursements for global health.

The U.S. Government has been the largest donor to global health in the world and its funding has included support for both disease (HIV, tuberculosis, malaria, and neglected tropical diseases) and population (maternal and child health, nutrition, and family planning and reproductive health) specific activities as well as global health security. Most U.S. funding for global health has been provided by Congress for bilateral efforts (approximately 80%). Of the multilateral share, the majority is provided to The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). The U.S. investment in global health grew significantly in the early 2000s, largely due to the creation of new initiatives including the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative (PMI), with spikes in funding in some years due to emergency supplemental funding for disease outbreaks, including Ebola and COVID-19. When this emergency funding is excluded, total support reached a peak level of $12.9 billion in FY 2023 but has declined each year since.1 In FY 2026, global health funding totaled $11.3 billion, its lowest level (through regular appropriations) since FY 2020.

Figure 1

U.S. Global Health Funding, FY 2017 - FY 2026 (Stacked column chart)

Figure 2

U.S. Global Health Funding (in millions), By Program Area, FY 2026 (Pie Chart)

Table 1

Historical Funding by Agency for Global Health, in millions (Table)

Global HIV Funding, Including PEPFAR

The U.S. first provided funding to address the global HIV epidemic in 1986. U.S. efforts and funding increased slowly over time until the launch of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) in 2003, which initiated a period of significant increases and is the largest effort devoted to a single disease in the world. The majority of U.S. global HIV funding has been provided by Congress for PEPFAR bilateral efforts (91%) with additional funding for UNAIDS and international HIV research activities. As part of its global HIV response, the U.S., which is the largest donor to HIV efforts globally, also provides funding to the Global Fund (see below for details).2 PEPFAR funding is specified by Congress in annual appropriations bills and is largely provided to the Department of State, which is responsible, through the Bureau for Global Health Security and Diplomacy (GHSD), for coordinating all U.S. programs, activities, and funding for global HIV efforts. Other agencies that have received HIV funding under PEPFAR include the U.S. Agency for International Development (USAID) (although in FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department), Centers for Disease Control and Prevention (CDC), and Department of Defense (DoD). In addition, the National Institutes of Health (NIH) supports international HIV research activities, (not counted as part of PEPFAR). Global HIV funding through regular appropriations3 has historically accounted for the largest share of the U.S. global health budget (ranging from 42% to 50% between FY 2017 and FY 2026). In FY 2026, global HIV funding totaled $5.2 billion, of which $4.8 billion is for PEPFAR4 ($4.7 billion for bilateral HIV and $45 million for UNAIDS), and approximately $418 million is for international HIV research activities at NIH.

Figure 3

U.S. Funding for Global HIV, FY 2017 - FY 2026 (Stacked column chart)

Table 2

Historical Funding by Agency and Account for Global HIV, in millions (Table)

Tuberculosis (TB)

Since 1998, when the U.S. Agency for International Development (USAID) began a global tuberculosis (TB) control program, U.S. involvement in global TB efforts has grown and the U.S. has been the largest donor to global TB efforts in the world.5  U.S. bilateral TB funding had been provided by Congress to USAID and included U.S. contributions to the TB Drug Facility (additional U.S. support for TB activities is provided through the U.S. contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria). In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. Over the last decade, U.S. funding for TB has grown, reaching a peak of $406 million in FY 2023, where it remained until decreasing slightly to $390 million in FY 2026. In FY 2026, U.S. funding for TB accounted for approximately 3% of the U.S. global health budget.

Figure 4

U.S. Funding for Global Tuberculosis (TB), FY 2017 - FY 2026 (Column Chart)

Table 3

Historical Funding by Agency and Account for Global Tuberculosis (TB), in millions (Table)

Malaria/PMI

The U.S. government has been involved in global malaria activities since the 1950s and, today, is the  largest donor government to global malaria efforts in the world (in addition, the U.S. is the largest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria, which in turn is the largest overall funder of global malaria efforts).6 The U.S. response to malaria had been driven by the President’s Malaria Initiative (PMI), an interagency initiative created in 2005 to address global malaria. PMI was led by the U.S. Agency for International Development (USAID), and co-implemented with the Centers for Disease Control and Prevention (CDC), with additional activities provided by the National Institutes of Health (NIH) and Department of Defense (DoD). In addition to bilateral funding, the U.S. also supports malaria programs through its contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria. In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. U.S. bilateral funding for malaria increased slightly over the past decade from $963 million in FY 2017 to approximately $1 billion in FY 2026. In FY 2026, malaria accounted for 9% of the U.S. global health budget.

Figure 5

U.S. Funding for Global Malaria, FY 2017 - FY 2026 (Column Chart)

Table 4

Historical Funding by Agency and Account for Global Malaria, in millions (Table)

The Global Fund to Fight AIDS, Tuberculosis and Malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) is an independent, public-private, multilateral institution which finances HIV, TB, and malaria programs in low- and middle-income countries. The Global Fund receives contributions from public and private donors and in turn provides funding to countries based on country-defined proposals. The U.S. provided the Global Fund with its founding contribution in 2001 and has since been its largest single donor (U.S. contributions to the Global Fund are counted as part of PEPFAR, although the Global Fund also supports TB and malaria efforts). The U.S. contribution to the Global Fund through regular appropriations has fluctuated over the past decade but reached its highest level to date ($2.0 billion) in FY 2023. In FY 2026, funding for the Global Fund was $1.25 billion, $750 million less than its peak level in FY 2023 and $400 million below the prior year level (FY 2025), in support of the administration’s pledge of $4.6 billion for the Global Fund’s eighth replenishment. In addition to regular appropriations, Congress provided $3.5 billion in emergency supplemental funding to the Global Fund to address the impacts of COVID-19 on HIV programs in FY 2021.

Figure 6

U.S. Funding for The Global Fund, FY 2017 - FY 2026 (Stacked column chart)

Table 5

Historical Funding by Agency and Account for the Global Fund to Fight AIDS, Tuberculosis and Malaria, in millions (Table)

Maternal & Child Health (MCH)

The U.S. has been involved in Maternal & Child Health (MCH) efforts since the 1960s (and has been a top donor to MCH activities in the world). MCH funding from Congress, which includes funding for polio and U.S. contributions to Gavi, the Vaccine Alliance (GAVI) and the United Nations Children’s Fund (UNICEF), had been appropriated to the U.S. Agency for International Development (USAID), the Centers for Disease Control and Prevention (CDC), and the State Department. In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. U.S. funding for MCH has been relatively flat over the past decade and totaled $1.29 billion in FY 2026, accounting for the third largest share of U.S. funding for global health (11%).

Figure 7

U.S. Funding for Global Maternal & Child Health (MCH), FY 2017 - FY 2026 (Column Chart)

Table 6

Historical Funding by Agency and Account for Global Maternal and Child Health (MCH), in millions (Table)

Nutrition

The U.S. has a long history of supporting global efforts to improve nutrition and has been the largest donor to nutrition efforts in the world. Starting in 2010, support for U.S. global nutrition activities had been appropriated through the U.S. Agency for International Development (USAID).7 In FY 2026, following the dissolution of USAID, funding that was previously provided through USAID was provided to the State Department. U.S. funding for nutrition increased from $148 million in FY 2017 to $165 million in FY 2026 and has accounted for relatively small share (approximately 1%) of the total U.S. global health budget over the period.

Figure 8

U.S. Funding for Global Nutrition, FY 2017 - FY 2026 (Column Chart)

Table 7

Historical Funding by Agency and Account for Global Nutrition, in millions (Table)

Family Planning & Reproductive Health (FP/RH)

The U.S. has been involved in Family Planning & Reproductive Health (FP/RH) efforts since the 1960s and has been the largest donor to global FP/RH in the world.8 The majority of U.S. FP/RH funding has been provided by Congress to the U.S. Agency for International Development (USAID) for bilateral activities, with additional funding provided through the State Department for a U.S. contribution to the United Nations Population Fund (UNFPA).9 In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. U.S. funding for FP/RH rose steadily in its first two decades10 and more recently, has remained relatively flat at just about $600 million, accounting for approximately 5-6% of the U.S. global health budget each year from FY 2017-FY 2026.11 (Unlike most other areas of global health, the Trump administration stopped all global FP/RH funding and activities in 2025, even though Congress continues to appropriate funding for this purpose).

Figure 9

U.S. Funding for International Family Planning/Reproductive Health (FP/RH), FY 2017 - FY 2026 (Column Chart)

Table 8

Historical Funding by Agency and Account for International Family Planning and Reproductive Health (FP/RH), in millions (Table)

Global Health Security

Since the 1990s, there has been growing concern about new infectious diseases that threaten human health including, in more recent years, the emergence and spread of threats such as Ebola, Zika, H1N1 influenza, COVID-19, and antibiotic resistance. U.S. global health security efforts aim to reduce the threat of emerging infectious diseases by supporting preparedness, detection, and response capabilities worldwide. Global health security funding had been provided by Congress to the U.S. Agency for International Development (USAID), the Centers for Disease Control and Prevention (CDC), and Department of Defense. In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. Over the past decade, funding designated by Congress for global health security through both emergency and regular appropriations has fluctuated over time, rising largely in response to outbreaks, including Ebola, Zika, and COVID-19.12 Funding for global health security as a share of the global health budget has increased over time, rising from 3% in FY 2017 to 10% in FY 2026 (after significant increases in funding during the COVID-19 pandemic, the overall amount has fallen annually over the past few years).13 In FY 2026, funding for global health security was $1.1 billion.

Figure 10

U.S. Funding for Global Health Security, FY 2017 - FY 2026 (Stacked column chart)

Table 9

Historical Funding by Agency and Account for Global Health Security, in millions (Table)

Neglected Tropical Diseases (NTDs)

NTDs are a group of parasitic, bacterial, and viral infectious diseases that primarily affect the most impoverished and vulnerable populations in the world. The U.S. Congress first designated funding to address NTDs in 2006, through the U.S. Agency for International Development (USAID).14 In FY 2026, following the dissolution of USAID, funding that was previously appropriated to USAID was provided to the State Department. Funding for NTDs has remained relatively flat over the past decade, fluctuating between $100 million and $115 million.15 Funding for NTDs accounts for a relatively small share of the U.S. global health budget (1% in FY 2026). Since NTDs efforts were not specifically mentioned in the new America First Global Health Strategy or accompanying bilateral global health agreements, it is unclear whether funding for NTDs will continue despite Congress providing the funding.

Figure 11

U.S. Funding for Global Neglected Tropical Diseases (NTDs), FY 2017 - FY 2026 (Column Chart)

Table 10

Historical Funding by Agency and Account for Neglected Tropical Diseases (NTDs), in millions (Table)

Endnotes

  1.  FY 2025 funding amounts do not take into account the $500 million in rescinded funding under the Global Health Programs account in the “Rescissions Act of 2025” (P.L. 119-28); areas that could be impacted by the rescissions include funding for family planning and reproductive health, global health security, the vulnerable children program, and neglected tropical diseases. ↩︎
  2. KFF, Donor Government Funding for HIV in Low- and Middle-Income Countries in 2024, July 2025. ↩︎
  3. In addition to regular appropriations, Congress provided $250 million in emergency supplemental funding to address the impacts of COVID-19 on U.S. bilateral HIV programs in FY 2021.   ↩︎
  4. Total PEPFAR funding in FY 2026 is $6.0 billion ($4.7 billion for bilateral HIV, $45 million for UNAIDS, and $1.25 billion for the Global Fund). ↩︎
  5. World Health Organization, Global Tuberculosis Report 2025, 2025. ↩︎
  6. World Health Organization, World Malaria Report 2025, 2025. ↩︎
  7. Totals do not include funding provided through Food for Peace (FFP) due to the unique nature of the program. ↩︎
  8. KFF, Donor Government Funding for Family Planning in 2024, November 2025. ↩︎
  9. Under current law, any U.S. funding withheld from UNFPA is to be made available to other family planning, maternal health, and reproductive health activities (see the KFF fact sheet on U.S. government international family planning and reproductive health statutory requirements and policies). ↩︎
  10. PAI. Cents and Sensibility: U.S. International Family Planning Assistance from 1965 to the Present. Accessed September 2022 at https://pai.org/cents-and-sensibility ↩︎
  11. FY 2025 funding amounts do not take into account the $500 million in rescinded funding under the Global Health Programs account in the “Rescissions Act of 2025” (P.L. 119-28); areas that could be impacted by the rescissions include funding for family planning and reproductive health, global health security, the vulnerable children program, and neglected tropical diseases. ↩︎
  12. In FY15, Congress provided $5.4 billion in emergency funding to address the Ebola outbreak, of which $909.0 million was specifically designated for global health security. In FY16, Congress provided $1.1 billion in emergency funding to address the Zika outbreak, of which $145.5 million was specifically designated for global health security. In FY18, Congress provided $100 million in unspent Emergency Ebola funding for “programs to accelerate the capabilities of targeted countries to prevent, detect, and respond to infectious disease outbreaks.” In FY19, Congress provided $38 million in unspent Emergency Ebola funding for “programs to accelerate the capacities of targeted countries to prevent, detect, and respond to infectious disease outbreaks.” In FY20, Congress provided $1.235 billion in emergency COVID-19 funding to “prevent, prepare for, and respond to coronavirus” globally, and in FY21, Congress provided $9.4 billion in emergency COVID-19 funding “to prevent, prepare for, and respond to coronavirus, including for vaccine procurement and delivery.” While none of the FY20 funding was designated for global health security, all of the FY21 funding provided through CDC ($750 million) was designated by CDC as global health security. ↩︎
  13. FY 2025 funding amounts do not take into account the $500 million in rescinded funding under the Global Health Programs account in the “Rescissions Act of 2025” (P.L. 119-28); areas that could be impacted by the rescissions include funding for family planning and reproductive health, global health security, the vulnerable children program, and neglected tropical diseases. ↩︎
  14. Additional NTD funding is used for NTD research at the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH), although this funding is not specified by Congress. ↩︎
  15. FY 2025 funding amounts do not take into account the $500 million in rescinded funding under the Global Health Programs account in the “Rescissions Act of 2025” (P.L. 119-28); areas that could be impacted by the rescissions include funding for family planning and reproductive health, global health security, the vulnerable children program, and neglected tropical diseases. ↩︎

Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

Published: Apr 21, 2026

Tracker

Section 1115 Medicaid demonstration waivers offer states an avenue to test new approaches in Medicaid that differ from what is required by federal statute, if [in the HHS Secretary’s view] the approach is likely to “promote the objectives of the Medicaid program.” They can provide states additional flexibility in how they operate their programs, beyond the considerable flexibility that is available under current law. Waivers generally reflect priorities identified by states as well as changing priorities from one presidential administration to another. Nearly all states have at least one active Section 1115 waiver and some states have multiple 1115 waivers. See the “Key Themes Maps” tab for a discussion of recent waiver trends.

This page tracks approved and pending Section 1115 waiver provisions (including expansions and restrictions) related to eligibility, benefits, and social determinants of health and other delivery system reforms, once such waivers are posted to the state waivers list on Medicaid.gov. For more information on inclusion criteria and on each provision, as well as a list of acronyms, see the Definitions tab.

Landscape of Approved and Pending Section 1115 Waivers (Stacked Bars)

 

Waivers with Eligibility Changes

(back to top)

Waivers with Benefit Changes

(back to top)

Waivers with SDOH & Other DSR Changes

(back to top)

All Approved Waivers by Topic

(back to top)

Approved Section 1115 Medicaid Waivers (Table)

All Pending Waivers by Topic

(back to top)

Pending Section 1115 Medicaid Waivers (Table)

Work Requirements

See KFF's Work Requirements Tracker for additional state and national-level data related to work requirement implementation, including related KFF resources on work requirements.

The 2025 reconciliation law requires states to condition Medicaid eligibility for adults in the ACA Medicaid expansion group on meeting work requirements starting January 1, 2027; however, states have the option to implement requirements sooner through a state plan amendment (SPA) or through an approved 1115 waiver.

State Plan Amendments (SPAs)

States may choose to implement work requirements prior to the required January 1, 2027 implementation date through a state plan amendment. Nebraska is the first state to announce that it will begin enforcing federal work requirements early through a state plan amendment, starting May 1, 2026. Two other states are also planning to implement before January 2027–Montana on July 1, 2026 and Iowa on December 1, 2026. Arkansas has announced that it plans to launch a soft implementation of work requirements on July 1, 2026 but will not disenroll individuals prior to January 1, 2027.

1115 Waivers

Since the start of the second Trump administration, several states have submitted waivers to implement work requirements. However, states are unlikely to be moving forward with proposed 1115 waivers at this time due to the passage of federal work requirements. States that plan to implement federal work requirements early will do so through a state plan amendment. Currently, Georgia is the only state with a Medicaid work requirement waiver in place following litigation over the Biden administration’s attempt to stop it. Georgia’s waiver will expire December 31, 2026; the state is required to come into compliance with the new federal requirements effective January 1, 2027.

Early Implementation and Waiver Status

The map below identifies states that have indicated they will implement work requirements early through a state plan amendment as well as approved (Georgia) and pending work requirement waivers (submitted to CMS since the start of the second Trump administration). The table below the map provides more detailed state waiver information.

States Implementing Work Requirements Early and/or Pursuing Work Requirement Waivers (Choropleth map)

States with Work Requirement Waiver Activity (Table)

Key Themes Maps

Section 1115 waivers generally reflect priorities identified by states as well as changing priorities from one presidential administration to another.  Key Biden administration 1115 initiatives included waivers addressing enrollee health-related social needs (HRSN), pre-release coverage for individuals who are incarcerated, and multi-year continuous eligibility for children.

In March 2025, the Trump administration rescinded HRSN guidance issued by the Biden administration. CMS indicates this does not nullify existing HRSN 1115 approvals but going forward they will consider HRSN / SDOH requests on a case-by-case basis. In April 2025, the Trump administration announced it would be phasing out federal funding for “Designated State Health Programs” (DSHP) in waivers. In July 2025, the Trump administration released guidance indicating it will not approve (new) or extend (existing) continuous eligibility waivers for children or adults. CMS also announced in July it would be phasing out initiatives to strengthen the Medicaid workforce for primary care, behavioral health, dental, and home and community based services (not depicted in maps below).

This page tracks pending and approved waivers in key areas of recent state activity and will track Trump administration action in these areas going forward. Hover over individual states to display waiver expiration dates.

Social Determinants of Health

Social determinants of health (SDOH) are the conditions in which people are born, grow, live, work and age. SDOH include but are not limited to housing, food, education, employment, healthy behaviors, transportation, and personal safety. In 2022, CMS (under the Biden administration) announced a demonstration waiver opportunity to expand the tools available to states to address enrollee “health-related social needs” (or “HRSN”) including housing instability, homelessness, and nutrition insecurity, building on CMS’s 2021 guidance. In 2023, CMS issued a detailed Medicaid and CHIP HRSN Framework accompanied by an Informational Bulletin, which were updated in 2024.

In March 2025, the Trump administration rescinded the Biden administration HRSN guidance. CMS indicates this does not nullify existing HRSN approvals but going forward they will consider HRSN / SDOH requests on a case-by-case basis.

The “HRSN Waivers” map below identifies states with approval under the Biden administration HRSN framework. The “All SDOH Waivers” map identifies SDOH-related 1115 waivers more broadly, including those that pre-date or were approved outside of the HRSN framework. For more detailed waiver information, refer to KFF’s Medicaid Waiver Tracker (“SDOH” table) and HRSN waiver watch  (March 2024).

Section 1115 Waivers: Social Determinants of Health (SDOH) (Choropleth map)

Medicaid Pre-release Coverage for Individuals Who Are Incarcerated

In April 2023, the Biden administration released guidance encouraging states to apply for a new Section 1115 demonstration opportunity to test transition-related strategies to support community reentry for people who are incarcerated. This demonstration allows states a partial waiver of the inmate exclusion policy, which prohibits Medicaid from paying for services provided during incarceration (except for inpatient services). Reentry services aim to improve care transitions and increase continuity of health coverage, reduce disruptions in care, improve health outcomes, and reduce recidivism rates. The Biden administration approved 19 state waivers to facilitate reentry for individuals who are incarcerated. The map below identifies states with approved and pending waivers to provide pre-release services to Medicaid-eligible individuals who are incarcerated.  Medicaid pre-release waivers have been pursued by both Republican and Democratic governors. For more information, refer to KFF’s Medicaid Waiver Tracker (“Eligibility Changes” table) and related pre-release waiver watch (August 2024).

Section 1115 Waivers: Medicaid Pre-release Coverage for Individuals Who Are Incarcerated (Choropleth map)

Multi-year Continuous Eligibility for Children

The Consolidated Appropriations Act, 2023 required all states to implement 12-month continuous eligibility for children beginning on January 1, 2024. The Biden administration approved 9 waivers that allow states to provide multi-year continuous eligibility for children (e.g., from birth to age six). Continuous eligibility has been shown to reduce Medicaid disenrollment and “churn” rates (rates of individuals temporarily losing Medicaid coverage and then re-enrolling within a short period of time).

In July 2025, the Trump administration released guidance indicating it will not approve (new) or extend (existing) continuous eligibility waivers for children or adults. The map below displays states with waiver approval to provide multi-year continuous eligibility for children.  For more information, refer to KFF’s Medicaid Waiver Tracker (“Eligibility Changes” table) and related continuous eligibility waiver watch (February 2024).

Section 1115 Waivers: Multi-year Continuous Eligibility for Children (Choropleth map)

Definitions

Section 1115 Waiver Tracker: Key Definitions and Notes (Table)

Related Resources

Recent Developments

General/Overview Resource

Eligibility and Enrollment Expansions

Eligibility and Enrollment Restrictions

Work Requirements:

Other:

Benefit Expansions

Benefit Restrictions, Copays, and Healthy Behaviors

Social Determinants of Health

Delivery System Reform

The Business of Health with Chip Kahn

Why KFF Is Launching a Podcast on the Business of Health

April 21, 2026

Video

Audio

About this Episode


To kick off our new show, KFF’s Business of Health with Chip Kahn, KFF’s Drew Altman explains how KFF is continually evolving to research, analyze and lead on health policy. Chip and Drew discuss how our new podcast will break down the business side of health care, artificial intelligence, and what it all means for health care delivery and patients. 

The Host


Headshot photo of Chip Kahn wearing a navy blue suit with a red tie, red pendant on lapel, and glasses.

Sr. Visiting Fellow

Charles N. Kahn III is a senior visiting fellow at KFF. He is also a visiting senior fellow at the American Enterprise Institute and a nonresident senior scholar at the University of Southern California’s Schaeffer Center for Health Policy & Economics. He serves as co-chair of the international Future of Health collaborative.

Guest


Photo of Drew Altman

Founding President & Chief Executive Officer

Drew Altman is founding president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

Transcript


Chip Kahn: Healthcare is about caring about the people who deliver it and the patients who depend on it. But to make that caring happen, to sustain it, and to meet the expectations of every patient who walks through the door, there is a business that has to work. This podcast is about that business. Welcome to KFF’s Business of Health. I’m Chip Kahn.

Americans who work in health care are driven by professionalism and mission. But professionalism and mission don’t run on good intentions alone. How care is financed, how it is delivered, how technology is deployed, how incentives are aligned. These are the forces that determine whether patients get the quality, the safety, and the outcomes they deserve. Health policy sets the rules of the road, but it is the business of health care, the decisions made every day by leaders who run systems, manage payment and allocate resources, that determines whether those rules translate into better care or not. In my view, that reality is often insufficiently understood by those who make policy and those who inform and advise the policy process. I see a gap between what the policy world knows about legislation and regulation and what it needs to know about a $5 trillion industry and how that industry operates. The intent of this podcast is to contribute to the closing of that gap, bringing those who provide the care and those who run systems, manage insurance, build technology, design, payment and allocate capital into direct conversation about the forces shaping American health care. Not theory, not commentary. The real world of health care delivery and financing.

The first series of this new podcast will begin with a subject that all of us need to understand. Artificial intelligence. Over the next several months, in an in-depth series, we will examine what AI is doing right now to, to health care, to clinical practice, to hospital operations, to clinical performance, to the patient experience and to how the industry is financed and structured. Our guests are those deploying this technology, managing its consequences and designing policy around it. From health systems leaders and clinician scientists to payer executives, technology leaders and regulators, we will cover the waterfront with those developing and contending with AI adoption in American healthcare. 

But for our very first episode, before we turn to the AI series, our inaugural guest will be Drew Altman, the president and CEO of KFF, who has led KFF for more than 30 years, creating the nation’s leading independent source of health policy research, polling and journalism. Drew is also the person who made this podcast possible. Drew Altman, welcome to KFF’s Business of Health. 

Drew Altman: Chip. Glad to be here. 

Chip Kahn: It’s great to have you. And you are the glue that makes all this work. So it’s a great way to start this podcast with you as our guest. Before we get into the business of health, why we’re doing it, what our purpose is, let’s talk about a broader context because it is KFF’s Business of Health. We’re part of KFF. So can you give us an idea of what you meant to do and what your purpose is in this organization, which is not a foundation anymore, it’s really something else. 

Drew Altman: No, we’re not a foundation. And Chip, before I answer your question, which I will answer, I want to welcome you, to our podcast. Thrilled to have you. This will add tremendously to our ability to talk about these cutting-edge issues and what’s going on in the private sector and in the marketplace and to reach new audiences. So it’s really important and welcome to you. 

Chip Kahn: Well, glad to be here. 

Drew Altman: KFF is an organization, well, we started a new organization, and I started it, quite some time ago. It’s almost embarrassing to talk about, but the basic idea was pretty simple. It was to build an organization which, through different kinds of information, heavy-duty policy analysis and research, polling and survey research, and our journalism, KFF Health News, now the largest health newsroom, in the country, could be hopefully, a trusted, independent source of information on these big controversial health care issues and a voice for people too, who sometimes don’t have a voice in, in our big healthcare debates. A little bit of a counterweight, to the money in politics that dominates health care over a long period of time. That kind of basic idea has worked out for us. And that’s it. It’s really, pretty simple. We don’t take positions, we don’t advance our own proposals. Trying to be as objective as we possibly can be through all of the research and the polling and the journalism isn’t neutral because nothing’s neutral in the shooting war now and the highly polarized environment we operate in. It’s been more than enough to make us different in the space in which we operate. And that recipe, that formula has worked out well for us over now more than three decades. 

Chip Kahn: But evidence is important and reality’s important. And I think that’s one of the things you’re trying to achieve here, is through the new service and through the research to get that information up to policymakers and the rest of the media and other opinion leaders, as well as giving an opportunity for the public to really better understand what the facts are. 

Drew Altman: You could certainly argue that facts and the institutions that provide them and the experts are on the ropes and don’t matter as much as they once did, but it’s a value for us. We believe we’re lost without them, that they really do matter. And one of the things I’ve discovered in recent years is while they may matter a little bit less, in some areas, maybe political campaigns, they really still do matter in many, for example, legislative debates where, what it costs, who’s affected, who wins and who loses. Just look at CBO scores, they really do matter. And we’ve seen our data, our facts about, for example, what, not extending ACA tax credits might or might not mean, really have a fundamental impact on discussion, and debate. And so we’re able to play a role. We have no delusions of grandeur, and we understand that we, by ourselves are not going to transform the healthcare debate in the U.S. but we think we can play, and we have played a role which is badly needed, honorable, and important, and that’s good enough for us. 

Chip Kahn: Well, and what excites me about being here is that you are a trusted outlet, because I hear people on both sides of the aisle, you know, discussing the information they get from KFF, whether it’s from the research or just.. 

Drew Altman: And we also get flack from both sides of the aisle, which is kind of my barometer. If I’m only getting flak from one side of the aisle, I get a little worried about what, we’re doing. And actually, it might surprise you which side we get the most flak from. Probably not what people would expect, but let’s just leave it at that. 

Chip Kahn: Well, what’s important is that you’re getting a lot of information out there. And that’s one of the things that attracted me in our initial discussions, was that I’ve been concerned for a long time. In all the work I’ve done over whether I worked on Capitol Hill or for the insurance industry or ultimately for hospitals, I’ve been concerned about policymakers, opinion leaders, media, particularly inside the Beltway, having a real grasp of what’s happening on the ground, to the care that Americans receive, to all those trying to provide the care. And that’s what led me to, our discussions about having this podcast developed around the business of health. How do you see it fitting in to the broader context of the organization you just described? 

Drew Altman: Well, a couple of things. First, building on that point, in everything that we do, all of the work that we do, we center people and patients. That’s just fundamental for us. What does it mean for real people and for patients? I’m particularly concerned right now, for example, about what’s happening with the chronically ill, who are the folks who are having the hardest time paying their health care bills. I mean, by far, I think of it as we throw around the word “crisis” too much. But if there is a crisis in health care costs for people in the country, it’s really people who use the health care system a lot, who experience, that crisis. We are in everything we do, all about, what does it mean for people, and for people who become patients because they use the health care system. This podcast is especially important because well, for a couple of reasons. One is to over generalize: people in the private sector don’t understand policy very well, and people in the policy world don’t understand the marketplace and the private sector very well. So we work hard at trying to build those bridges. This podcast is part of that. But more importantly, the changes that are occurring in the private sector, take AI as an example, or private equity, or just all of the changes occurring in payment, and delivery are occurring incredibly rapidly. So many of them are impossible to capture in a definitive study or analysis or to survey the public about some of the nuances of private. We do survey them, but some of the nuances of, say, private equity or what’s happening with value hospital payment, people don’t know what that is. And so it is through a podcast like this and through you, that we’re able to bring in people who have their finger on the pulse of the changes that are happening just as they’re happening. The best experts in the country who are also on the front lines to try and help everyone understand what does this mean? What really, actually is happening. Otherwise they have to wait two, three, four years to get data, or maybe we will never get data about what’s actually, happening so that we can write the perfect policy brief. Well, we don’t have the perfect policy brief on what’s happening in the marketplace. So this really adds tremendously to our ability to be nimble and move fast, understand what’s happening. We have an analogous initiative on the policy side, which Larry Levitt moderates called The Health Wonk Shop, where we try and do something similar. But we really wanted to be able to focus on the rapidly moving changes occurring in the marketplace. 

Chip Kahn: And that care really depends on. For the title we call it business, but it really is the infrastructure that all Americans depend on for their health care, where they receive their health care, where the research is done that produces the medical miracles that’ll hopefully allow them to live longer and live healthier. all Those things are dependent on this infrastructure. And the infrastructure is facing a lot of challenges. 

And that’s why I’m glad, you and Larry came up with the idea that I should start off with AI in health care in terms of a podcast series. Because AI could be the greatest disruptor of that infrastructure, could enhance the infrastructure tremendously. But it challenges that infrastructure. We’re up against it now. Hopefully over the next 20 or so episodes, our audience is going to see the impact of this being really unprecedented. 

Drew Altman: This is a little bit, of an indelicate way to make the point, but I really agree with that and believe that a thousand years ago we were living in Philadelphia, my wife was running a children’s hospital and I was working in policy and we got annoyed with one another and she said to me, I do health care and you do bs. And there was some truth to that. And I just have a deep respect for, I, don’t even use the word provider for health professionals and health care institutions. But what it really comes down to is understanding what’s actually happening on the front lines and in institutions and to patients and to people. And really that is what I hope will be KFF’s emphasis as AI unfolds. Because I attend all, you know, the conferences too, and speak at many of them. And there’s tremendous focus. We need to focus on it, on what it means for business opportunities and what it means for research and what it means for diagnosis. And I don’t hear a lot of discussion about what it means for people and for patients, who our surveys show are distrustful of it, or may even increasingly be using AI as their doctor because they can’t get care otherwise or afford it or don’t then follow up with a doctor when they get some information from AI about what they think might be a medical problem. So these are just things we need to sort out. And I think starting with AI and with an elaborate 18 part series on AI, is just exactly the right place to start. 

Chip Kahn: Yeah, we’re going to try to cover the waterfront. I mean there are a lot of good podcasts on AI. I don’t think anybody’s done it as thoroughly as we plan. And I hope after this, it’ll provide anyone who is listening as we come out every week or binging at some point in the future. They’ll leave it really having a good understanding of the challenges. 

Drew Altman: And we’ll continue also to do our surveys of how people are and are not using AI in healthcare. We’ll also continue through another part of the organization to look at AI’s role in misinformation both spreading misinformation but also as a way to monitor it and hopefully put it all together amounting eventually to our own significant effort on AI. We are trying to figure out what is our role in AI and also how do we use it in our own work which is a different subject. 

Chip Kahn: Well Drew, I want to thank you again for this opportunity. We’re going to start in a week with launching our first series on AI and health care with Eric Larsen. I think we’re going to set a good foundation and then really do something that I hope our listening public will appreciate and will inform them in a way that almost no one else has, and just thank you. Glad to be here and look forward to working with KFF into the future. 

Drew Altman: Terrific. I hope everyone learns a lot and also has some fun. Thanks. 

AI Usage Disclosure: This transcript was created with assistance from AI tools. It was reviewed and edited by KFF Staff.


SERIES

This weekly podcast features insightful conversations between host Chip Kahn and his guests, who discuss the business of health care, connecting the dots between the health care business, policy, and patients.

The podcast’s first series on AI in health care illuminates how AI is changing health care, and features guests who are deploying this technology, managing its consequences, and designing policy around it.

How Employers Support Lower-Waged Workers’ Access to Health Insurance Options

Published: Apr 20, 2026

Health insurance makes up 8% of total employee compensation on average, and while most employees take up health insurance when it is offered, lower-wage workers are far less likely to be able to access coverage, according to an analysis on the costs, availability, and take-up of health benefits for workers with lower wages. The analysis uses survey data and information from focus groups discussions with more than 100 U.S. employers with over a quarter of a million employees.

About three in four employees are offered health insurance on average, and nearly two-thirds of those offered insurance enroll in the benefit. Workers in occupations with lower wages, such as service occupations, are much less likely to have access to health benefits at their jobs (94% of workers in higher-wage jobs vs. 44% in lower-wage jobs) and, even when they do, they are much less likely to enroll (72% vs. 49%).

The analysis of part of the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.

UNFPA Funding and Kemp-Kasten: An Explainer

Published: Apr 17, 2026

Editorial Note: Originally published in April 2017, this resource is updated as needed to reflect the latest developments.

Key Points

  • On May 8, 2025, the Trump administration invoked the “Kemp-Kasten amendment” in order to withhold FY 2025 funding for the United Nations Population Fund (UNFPA, the lead U.N. agency focused on global population and reproductive health); the same determination was made during President Trump’s first term. FY 2025 funding for UNFPA was expected to total $32.5 million in core support and potentially millions more for other project activities.
  • While under current law any U.S. funding withheld from UNFPA is to be made available for other family planning, maternal health, and reproductive health activities, Congress rescinded (permanently canceled) FY 2025 funding appropriated for UNFPA as part of a broader foreign aid rescission package requested by the President. Although Congress again appropriated $32.5 million in core support for UNFPA for FY 2026, it is expected that President Trump will again withhold the funds from the organization.
  • The Kemp-Kasten amendment is a provision of U.S. law, first enacted by Congress in 1985 and included in appropriations language annually, that states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization.”
  • Kemp-Kasten has often been used, as determined by presidents along party lines, to withhold U.S. funding to UNFPA. While framed broadly, Kemp-Kasten was originally intended to restrict funding to UNFPA specifically, after concerns arose about China’s population control policies and UNFPA’s work in China; to date, it has only been applied to UNFPA. Evaluations by the U.S. government and others have found no evidence that UNFPA directly engages in coercive abortion or involuntary sterilization in China, and more generally, UNFPA does not promote abortion as a method of family planning or fund abortion services.
  • Kemp-Kasten has been used to withhold funding from UNFPA in 20 of the past 41 fiscal years.

What is the Kemp-Kasten Amendment?

The Kemp-Kasten amendment, first enacted in 1985, is a provision of U.S. law that states that no U.S. funds may be made available to “any organization or program which, as determined by the [p]resident of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization.”1 It was the congressional response to a Reagan administration decision in 1984 to temporarily withhold some funding from UNFPA and to begin conditioning its funding on assurances that the agency did not engage in or provide funding for abortion or coercive family planning. This policy change was made after concerns arose about whether UNFPA supported China’s coercive population policies.2 It was announced by the Reagan administration at the 2nd International Conference on Population in 1984, in conjunction with the “Mexico City Policy.”3 The Mexico City Policy originally required foreign NGOs to certify that they would not “perform or actively promote abortion as a method of family planning” with non-U.S. funds as a condition of receiving U.S. family planning assistance; the Trump administration recently expanded this restriction to encompass more funding, more organizations, and more policy areas (see the KFF explainer on the policy).

Box 1: The Original Language Regarding UNFPA in the U.S. Policy Statement at the 2nd International Conference on Population, 1984

“With regard to the United Nations Fund for Population Activities [UNFPA], the US will insist that no part of its contribution be used for abortion. The US will also call for concrete assurances that the UNFPA is not engaged in, or does not provide funding for, abortion or coercive family planning programs; if such assurances are not forthcoming, the US will redirect the amount of its contribution to other, non-UNFPA, family planning programs.”4

What U.S. funding does Kemp-Kasten apply to?

Kemp-Kasten applies to all funds appropriated under the State and Foreign Operations appropriations act as well as any unobligated balances from prior appropriations. This includes all funding provided to the State Department and the now-dissolved USAID, which, in turn, includes the vast majority of U.S. global health funding.5

When has Kemp-Kasten been in effect?

The Kemp-Kasten amendment has been in effect for 41 years. First enacted in 1985,6 its language has been included in the State and Foreign Operations appropriations act every fiscal year since then. (Although the provision is present in current law, language similar to Kemp-Kasten was also included in President Trump’s presidential memorandum reinstating the Mexico City Policy on January 24, 2025.7) While Congress has kept the amendment in place annually, it remains up to the president to determine whether or not to invoke Kemp-Kasten as a reason to withhold funding from an organization (see below).8

Though Kemp-Kasten technically could apply to funding provided to any organization or program (including U.S. NGOs, non-U.S. NGOs, multilateral organizations, and foreign governments), the U.S. government has issued determinations about only one organization, UNFPA, thus far. The U.S. played a key role in the launch of UNFPA in 1969 and was, until 1985, the largest government donor to the agency.9 However, the U.S. has withheld funding from UNFPA due to presidential determinations that it violated Kemp-Kasten as often as it has provided funding since 1985 (in 20 of the past 41 fiscal years, to date), and in some years, funding was also withheld from UNFPA based on other provisions of the law, such as the dollar-for-dollar withholding requirement10 (see below). These determinations have been made along party lines with only one exception – the first year of President George W. Bush’s administration (see Figure 1 and Table 1).

How much funding does the U.S. provide to UNFPA?

In 2024, the U.S. was the largest donor to UNFPA, having provided 17% of all contributions. Total funding from the U.S. for UNFPA was $231.8 million – $30.5 million in core support and $201.3 million for other projects – in FY 2024 (see Box 2).11 See Figure 1 and Table 1 for historical funding data.

Box 2: Core and Non-Core Support to UNFPA

According to UNFPA, contributions to core resources allow the agency to support any activity, while contributions to non-core resources – funds earmarked for a specific purpose – may only be used for the stated project or activity.12 Governments provide contributions toward UNFPA core and non-core resources on a voluntary basis, since UNFPA does not assess a required contribution from governments.

U.S.
Funding for UNFPA, FY 1985 - FY 2025 (Bar Chart)
Kemp-Kasten and U.S. Funding for UNFPA (Core Support Only), FY 1985–FY 2027 (Table)

How is a determination about Kemp-Kasten made?

By law, it is up to the president to determine whether any organization or program should be ineligible for funding due to a violation of the Kemp-Kasten amendment (in practice, this authority has generally been delegated to the State Department). In most recent years, legislative language has also specified that this determination must be: 1) made no later than six months after the date of enactment of the law that includes the provision and 2) accompanied by the evidence and criteria used to make the determination.13

Most recently, on January 24, 2025, at the beginning of his second term, President Trump directed the Secretary of State to begin the process of making a Kemp-Kasten determination by taking “all necessary steps,” and in May 2025, the United States again invoked Kemp-Kasten to withhold funding from UNFPA. These determinations are usually made after the annual appropriations process is completed. For example, in 2017, the Trump administration’s determination was made on March 30, 2017, at the six month mark after the passage of the FY 2017 continuing resolution appropriations bill and was accompanied by a two-page justification memorandum.14

Has there ever been evidence that UNFPA supports coercive abortion or involuntary sterilizations?

To date, there has been no evidence that UNFPA supports coercive abortion or involuntary sterilizations. Several evaluations by the U.S. government (including one by an assessment team sent to China by the State Department in 2002) as well as other groups, such as the British All-Party Parliamentary Group on Population, Development, and Reproductive Health (in 2002) and the Interfaith Delegation (in 2003), have found no evidence of direct engagement by UNFPA in such activities in China or elsewhere.15 In addition, UNFPA does not promote abortion as a method of family planning or fund abortion services.16 In years when a determination has been made that UNFPA violated Kemp-Kasten, the U.S. government has stated that the determination was based on its conclusion that UNFPA support to or partnering with the Chinese government for other population and reproductive health activities was sufficient grounds for invoking the amendment to withhold funding. In the March 30, 2017, determination by the Trump administration, for example, the justification memorandum stated that: “While there is no evidence that UNFPA directly engages in coercive abortions or involuntary sterilizations in China, the agency continues to partner with the NHFPC [China’s National Health and Family Planning Commission] on family planning, and thus can be found to support, or participate in the management of China's coercive policies for purposes of the Kemp-Kasten amendment.”

What other legislative requirements apply to U.S. funding for UNFPA?

In addition to Kemp-Kasten, there are several other provisions of law that Congress has enacted in recent years to set conditions on U.S. funding for the agency.17 These provisions:

  • require UNFPA to keep U.S. funding to the agency in a separate account, not to be commingled with other funds;
  • prohibit UNFPA from funding abortion;
  • prohibit UNFPA from using any U.S. funds for their programming in China;
  • reduce the U.S. contribution to UNFPA by one dollar for every dollar that UNFPA spends on its programming in China (“dollar-for-dollar withholding”); and
  • in some years, state that not more than half of funding designated for the U.S. contribution to UNFPA is to be released before a particular date, which varies by fiscal year (this provision is not currently in effect).

What happens to funding that is withheld from UNFPA?

For several years, including FY 2025 and FY 2026, Congress has required that funding withheld from UNFPA be reallocated to U.S. global family planning, maternal, and reproductive health activities. (However, despite this requirement, the withheld FY 2025 contribution to UNFPA will not be reallocated to those purposes since shortly after the Trump administration made its Kemp-Kasten determination that year, Congress rescinded, or permanently canceled, the funding as part of a larger foreign aid rescission package requested by the President.18) The enactment of this provision first affected reallocation of FY 2002 funds.19 It is now typically included in the State and Foreign Operations appropriations act each year.20


  1. U.S. Congress, FY 2017 Consolidated Appropriations Act (P.L. 115-31), May 5, 2017; KFF, The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies, fact sheet. ↩︎
  2. Congressional Research Service (CRS), The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010; “Policy Statement of the United States of America at the United Nations International Conference on Population (Second Session), Mexico City, Mexico, August 6-14, 1984,” undated. ↩︎
  3. “Policy Statement of the United States of America at the United Nations International Conference on Population (Second Session), Mexico City, Mexico, August 6-14, 1984,” undated; United Nations Division of Economic and Social Affairs/Population Division, “United Nations Conferences on Population,” webpage, undated, http://www.un.org/en/development/desa/population/events/conference/index.shtml. ↩︎
  4. “Policy Statement of the United States of America at the United Nations International Conference on Population (Second Session), Mexico City, Mexico, August 6-14, 1984,” undated. ↩︎
  5. KFF, The U.S. Congress and Global Health: A Primer; and KFF U.S. Global Health Budget Tracker, available at: https://www.kff.org/interactive/u-s-global-health-budget-tracker/. ↩︎
  6. Via FY 1985 supplemental appropriations, per CRS, The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010. ↩︎
  7. Specifically, in this memorandum, President Trump stated, “I further direct the Secretary of State to take all necessary actions, to the extent permitted by law, to ensure that U.S. taxpayer dollars do not fund organizations or programs that support or participate in the management of a program of coercive abortion or involuntary sterilization.” ↩︎
  8. However, after UNFPA ended its program in China in 1997 but then began a new program there in 1999, this resulted in Congress withholding funding from UNFPA that year. ↩︎
  9. CRS, The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010; PAI, Why the United States Should Maintain Funding for UNFPA, May 2015. ↩︎
  10. In FY 1999, Congress prohibited UNFPA funding in response to the initiation of a new UNFPA program in China (this was unrelated to Kemp-Kasten), and in some other years when the U.S. made a contribution to UNFPA, UNFPA’s China program meant some UNFPA funding was withheld under the “dollar-for-dollar withholding” provision. ↩︎
  11. KFF analysis of data from State Department, U.S. Contributions to International Organizations: Reports to Congress, available at: https://www.state.gov/u-s-contributions-to-international-organizationshttps://bidenwhitehouse.archives.gov/briefing-room/presidential-actions/2021/01/28/memorandum-on-protecting-womens-health-at-home-and-abroad/https://www.whitehouse.gov/briefing-room/presidential-actions/2021/01/28/memorandum-on-protecting-womens-health-at-home-and-abroad/. ↩︎
  12. UNFPA, Annual Report 2013, 2014. ↩︎
  13. Typically included in annual State and Foreign Operations appropriations since FY 2008, including in FY 2017 under the terms of the continuing resolution. CRS, The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010; KFF analysis of appropriations bills. ↩︎
  14. State Department: Letter to Bob Corker, Chairman, Committee on Foreign Relations, from Joseph E Macmanus, Bureau of Legislative Affairs, State Department, dated April 3, 2017, and accompanying “Determination Regarding the ‘Kemp-Kasten Amendment,’” dated March 30, 2017, and “Memorandum of Justification for the Determination Regarding the "Kemp-Kasten Amendment,” undated. Available online (follows the article) at: https://www.buzzfeednews.com/article/jinamoore/the-us-wont-give-any-more-money-to-the-un-population-fund. ↩︎
  15. CRS, The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010. ↩︎
  16. UNFPA, “Frequently Asked Questions,” webpage, updated January 2025, http://www.unfpa.org/frequently-asked-questions#abortion. ↩︎
  17. KFF, The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies, fact sheet. ↩︎
  18. KFF analysis of Congressional Appropriations Bills. ↩︎
  19. “Although such reallocation began in practice in FY 2002, it was first authorized by Congress in legislation beginning in FY 2004 with reference to FY 2002 and FY 2003 funds,” per KFF, The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies, fact sheet. ↩︎
  20. The activities to which Congress directs reallocated funds varies by fiscal year; in FY 2003, for example, reallocated funding supported assistance to vulnerable children and victims of trafficking in persons. CRS, The U.N. Population Fund: Background and the U.S. Funding Debate, RL32703, July 2010. ↩︎

What Are the Recent Trends in Employer-Based Health Coverage?

Published: Apr 17, 2026

Employer-sponsored health insurance is the largest source of health coverage for people under 65, covering 165.6 million people in March 2025, but its reach is uneven. About four in five (80%) adult workers under age 65 work for an employer that offers health insurance to at least some employees—a share that falls to 60% for lower-paid workers. Additionally, some workers do not enroll even when coverage is offered: employer-sponsored health insurance covered only 22.5% of people under 65 with incomes below 200% of poverty—compared to 82.5% of people with incomes of at least 400% of poverty.

This analysis examines who among people under 65 have employer coverage and which workers are offered and eligible for coverage at their jobs, using the Annual Economic and Social (March) Supplements of the Current Population Survey.

The analysis of part of the Peterson-KFF Health System Tracker, an online information hub dedicated to monitoring and assessing the performance of the U.S. health system.

Employer-Sponsored Health Insurance 101

Table of Contents

Introduction

Copy link to Introduction

Employer-sponsored health insurance (ESI) is the largest source of health coverage for U.S. residents under age 65. Unlike many other nations, the U.S. relies on voluntary, private health insurance as the primary source of coverage for residents who are not elderly, poor or disabled. Providing health insurance through workplaces is an efficient way of offering coverage options to working families, and the tax benefits of employer-based coverage further enhance its attractiveness. Yet ESI often results in uneven coverage, especially for those with low wages or those working at smaller firms. Overall, 60% of people under age 65, or about 165.6 million people, had employment-sponsored health insurance in 2025. The level of coverage varies significantly with income and other factors, even among working families.

Editorial Note: The estimate for the number of people with employer-sponsored health insurance includes all people under age 65, regardless of whether they report multiple types of coverage. A KFF analysis of the American Community Survey (ACS) found that 154 million people under age 65 are covered by employer-sponsored health insurance in the United States. To produce this estimate, coverage is assigned using a hierarchy, so each person reporting more than one type of insurance is counted under a single category.

What Is Employer-Sponsored Health Insurance?

Copy link to What Is Employer-Sponsored Health Insurance?

There are several ways people get private health insurance. One is by purchasing coverage directly from an insurer, often with the help of an insurance agent or through an online platform such as Healthcare.gov. Income-based premium assistance is available under the Affordable Care Act (ACA). This is called individual or non-group health insurance. The second is coverage under a policy or plan offered by a sponsoring group, such as an employer, union or trade association. This is called group health insurance. When an individual is sponsored specifically by an employer (or sometimes jointly by one or more employers and a union or by a group of employers), it is often referred to as employer-sponsored health insurance, or ESI.

The word “insurance” is something of a misnomer here. An employer providing health benefits for workers and their families (“plan enrollees”) can fund them in one of two ways. Employers may purchase a health insurance policy from a state-licensed health insurer, which is referred to as an insured plan. Alternatively, the employer can pay for health care for the plan enrollees directly with its own assets, referred to as a self-funded plan. Employers with self-funded plans often protect themselves from unexpected high claim amounts or volume by purchasing a type of insurance referred to as stop-loss coverage. As discussed below, most ESI plan enrollees are covered by large employers, and most large employers self-fund their health benefit plans.

Another confusing set of phrases used in conjunction with health insurance, including ESI, is “health plan” or just “plan”. The terms can refer to an entity offering coverage (e.g., Aetna) or a particular coverage option offered by an insurer or employer (e.g., the PPO plan option). However, the terms “employee benefit plan” and “plan” have specific meanings in federal law, and invoke several legal obligations for employers when they offer certain benefits to their workers and their family members. Under the Employee Retirement Income Security Act, or ERISA, an employee benefit plan, or plan, is created when a private employer creates a plan, fund or program to provide certain benefits, including health benefits, to employees. ERISA creates a structure of disclosure, enforcement and fair dealing regarding the promises made by employers to enrollees in employee benefit plans. However, ERISA does not apply to the health benefit plans created by public plans or churches, although the word plan is often still used to describe benefits offered in these settings.

ESI plans can be differentiated across several dimensions.

Comprehensive or limited benefits

Employers offer different types of health benefit options to employees. These include comprehensive benefit plans, which cover a large share of the cost of hospital, physician and prescription costs that a family might incur during a year; service-specific benefits, such as dental or vision care plans; and supplemental benefit plans, which may provide a limited additional benefit to enrollees if certain circumstances occur (e.g., $100 per day if hospitalized). The discussion here will be limited to comprehensive benefit plans.

Open or closed provider networks

Health plans contract with hospitals, physicians, pharmacies and other types of health providers to provide plan enrollees with access to medical care at a predetermined cost. Plan enrollees receiving services from one of these providers know that their financial liability is limited by their deductible and other cost-sharing amounts specified in their benefit plan. A closed-network plan is one where, absent special circumstances, an enrollee is only covered if they receive care from a provider in their plan’s network of contracted providers. In an open-network plan, an enrollee still has some coverage if they receive care from a provider not in the plan network, although they will likely face higher cost sharing under their benefit plan, and the provider may ask them to pay an additional amount (known as balance billing). Health maintenance organization (HMO) and exclusive provider organization (EPO) plans are two types of closed network plans. Preferred provider organization (PPO) and point of service (POS) plans are two types of open network plans.

Small and large group markets

Federal and state laws divide ESI into the small group and the large group market, based on the number of full-time equivalent employees (FTEs) working for the employer sponsoring the plan. Federal regulation states that employers with fewer than 50 FTEs are often in the small group market and employers with at least 50 FTEs are in the large group market. However, states have the option to raise the small group market limit to fewer than 100 FTEs. The regulatory requirements for the small and large group markets differ somewhat. Generally, the small group insured market is subject to more extensive rules about benefits and ratings. Large employers are potentially subject to financial penalty under the ACA if they do not offer health insurance coverage meeting certain requirements to their full-time employees.

Are Employers Required to Offer Health Benefits?

Copy link to Are Employers Required to Offer Health Benefits?

The drafters of the ACA intended to provide coverage options to those without access to employer-sponsored coverage without encouraging employers to drop coverage. To achieve this balance, the ACA requires that employers with at least 50 FTEs offer health benefits which meet minimum standards for value and affordability or pay a penalty. The so-called ‘employer mandate’ constitutes two separate penalties.

First, employers are taxed if they do not offer minimum essential coverage to 95% of their full-time employees and their dependent children. This generally requires that employers offer major-medical coverage and not a limited benefit plan. Employers face this penalty when at least one of their employees receives an advance premium tax credit (APTC) to purchase coverage on the health insurance exchange markets or Marketplaces. In 2025, this penalty stipulates that employers will be assessed a tax of $2,900 for each full-time employee after their first 30 employees.

Secondly, employers are penalized if the coverage they offer is not affordable or does not provide minimum value. Plans are considered to meet the minimum value standard if they cover 60% of the health spending of a typical population. In 2025, coverage was deemed to be affordable if the employee premium contribution was less than or equal to 9.02% of their household income. Employers may be charged $4,350 for each employee enrolling in subsidized Marketplace coverage.

Defining what constitutes ‘affordable’ has been the focus of considerable attention in recent years. The Obama administration initially issued rules that workers and their dependents would be considered to have an affordable offer if self-only coverage met the affordability test. With many employers requiring much larger premium contributions to enroll dependents, this meant that as many as 5.1 million people were in households where they had to pay a larger share of their income to enroll in the plan offered by their employers without being eligible for premium tax credits. Recent rules have addressed the so-called “family glitch” by considering the cost of family coverage when assessing affordability. While most large employers offer health benefits, many may encourage spouses and other dependents to enroll in other plans if possible. For more information on eligibility for premium credits see the Affordable Care Act chapter.

Why Is Employer-Sponsored Health Insurance So Dominant?

Copy link to Why Is Employer-Sponsored Health Insurance So Dominant?

ESI is by far the most common source of private health insurance. There are two primary reasons for this. The first is that providing health insurance through the workplace is efficient, with advantages relating both to risk management and to the costs of administration. The second is that contributions towards premiums by employers and (in most cases) by employees are not subject to income or payroll taxes, providing a substantial federal and state subsidy towards the costs of ESI.

ESI Efficiencies

When people have choices about whether to buy insurance and the amount of coverage to buy, it is natural that people with the highest need for coverage (e.g., people in poorer health) will be more likely to purchase and be more willing to pay higher prices. This is called adverse selection. If insurers do not address these tendencies, their risk pools will become dominated by a relatively small share of people with the highest needs, and premiums will increase to levels that only make sense for those with very high expected costs.

There are several ways insurers seek to manage the risk profile of potential enrollees to avoid adverse selection. One is by examining the health profile of each applicant, which typically includes the applicant’s health history and pre-existing conditions. This strategy is reasonably effective, but an expensive and time-consuming process. A much lower-cost approach is to provide coverage to groups of people who are grouped together for reasons other than their health or their need for health insurance. Providing coverage through the workplace is a common way of doing this. Mostly, people choose a job because of the work, not because they need health insurance. Therefore, providing coverage through workplaces provides insurers with a fairly normal mix of healthy and less healthy enrollees if certain conditions are met. These conditions include enrolling a large share of the eligible workers in coverage (typically achieved by the employer paying a large share of the cost) and limiting the range of coverage options (to avoid adverse selection among plan types). Further, as the number of employees grows, the ability to predict future costs based on prior experience also increases, reducing the uncertainty in setting premiums for the group. As uncertainty decreases, insurers can reduce what they charge for insuring the group. Overall, the same scenario generally applies to situations where employers choose to offer a self-funded plan. Therefore, these advantages occur regardless of whether an insurer or an employer is taking on the risk.

In addition to the risk management advantages, ESI has many administrative advantages. Providing coverage through a workplace adds many employees to a risk pool through a single transaction, with no need to examine their health in most cases. Employers also provide and collect enrollment information to workers and collect the employee share of premiums, dramatically reducing the number of transactions and reducing the amount of unpaid premiums that typically occur when individuals purchase insurance directly from insurers.

Tax Advantages

Federal and state tax systems provide significant tax preferences for ESI. Generally, wages and other things of value employers provide as compensation to their workers are subject to federal and state taxes. The federal government taxes wages and other forms of income through a series of marginal rates that vary with income and the marital and filing status of the taxpayer. For example, the lowest marginal rate in 2024 for a single taxpayer was 10% for income below $11,601 and the highest rate was 37% for income above $609,350. Additionally, wages are subject to federal payroll taxes to support the Social Security and Medicare programs; employers and employees are each assessed 6.2% of wages up to a maximum wage for Social Security and 1.45% of wages with no wage limit for Medicare. Wages are also subject to state income and payroll taxes for unemployment, which vary considerably.

Unlike wages, ESI provided by employers as part of their compensation to employees is not considered income under the federal income tax code, nor are they considered wages subject to federal payroll taxes (See 26 USC sections 105 and 106). Federal law also permits employers to establish programs that exclude employee contributions towards ESI from these taxes. These exclusions lower the cost of health insurance for employees. For example, just considering the federal tax advantages, if an employee earns annual wages of $100,000, an employer can provide the employee with a $20,000 family policy for an additional $20,000 in compensation. However, if ESI were subject to federal taxes, that same employee would need to earn an additional $27,460 in wages to be able to buy a $20,000 family policy with after-tax dollars, assuming a 22% marginal federal income tax rate and a combined 15.3% payroll tax for Social Security and Medicare. Looked at another way, for this employee, for every dollar that the employer raises the employee’s compensation, the employee can get a dollar of health benefits or just under 63 cents in wages after taxes. State tax laws, which follow federal definitions of income and wages in this situation, further lower the cost of ESI for workers, although the impacts are much smaller.

The exclusion of ESI from federal income tax is a long-standing and somewhat controversial part of federal tax policy, first appearing due to a decision by the War Labor Board in 1942, which in turn allowed employers to use fringe benefits to attract workers during the war. In 1954, ESI exclusion was enacted in the tax code. This tax policy, combined with the risk management and administrative advantages of group coverage, contributed to the rapid growth and continued market dominance of commercial hospital and medical insurance during this period. Detractors of the tax exclusion have argued that it encourages workers to over-consume health insurance by demanding health benefits that are richer than what they would want under a tax-neutral approach (e.g., if health benefits were taxed in the same way as wages). Richer benefits, it is argued, contribute to higher health care costs because people with better insurance use more health care than they otherwise would, since they are not facing the actual costs of care (sometimes called moral hazard). Another criticism is that the income tax exclusion favors higher-paid employees because they have higher marginal tax rates: the effective income tax benefit for a dollar of ESI is only 10 cents for a worker with very low wages but can be up to 37 cents for those with the highest wages.

In contrast, the exclusion of health benefits from payroll taxes has the same dollar benefit for workers at all wage levels (up to the Social Security earnings limit), which results in a higher percentage exclusion (share of wages) for those with lower wages. The tax exclusion was estimated to cost the federal government $312 billion (about $940 per person in the U.S.) in income and payroll taxes in 2022.

Who Is Covered by Employer-Sponsored Health Insurance?

Copy link to Who Is Covered by Employer-Sponsored Health Insurance?
Share of individuals under 65 with employer-sponsored health insurance (ESI), overall and by poverty level, March 2025 (Bar Chart)

As of March 2025, 60.0% of people under age 65, or about 165.6 million people, had ESI. Of these, 85.7 million had ESI from their own job, 73.6 million were covered as a dependent by someone within their household, and 6.3 million were covered as a dependent by someone outside of their household.

A relatively small share of these people also held other coverage at that time: 3.0% were also covered by Medicaid or other public coverage and 0.8% were also covered by non-group coverage.

ESI coverage varies dramatically with income. In March 2025, more than 4 in 5 (82.5%)adults under age 65 with incomes at least 400% of the federal poverty level (FPL) had ESI, compared to 57.2% with incomes between 200% and 399% of the FPL and 22.5% with incomes below 200% of the FPL. ESI also varies with age, as well as other worker characteristics. Among people under the age of 65 in March of 2025, people in younger age groups were less likely than those in older age groups to have ESI, and U.S. citizens were much more likely than non-citizens to have ESI. ESI coverage also varied across race and ethnic categories: compared to non-Hispanic White people, Hispanic people and non-Hispanic people who are Black, American Indian or Alaskan Native, Native Hawaiian or other Pacific Islander, or of mixed race were less likely to have ESI.

Share of individuals under 65 with employer-sponsored health insurance (ESI), by select characteristics, March 2025 (Bar Chart)

How Many Workers Have Access to Employer-Sponsored Health Insurance at Their Job?

Copy link to How Many Workers Have Access to Employer-Sponsored Health Insurance at Their Job?

For people in working families to have ESI, one or more workers must work for an employer that makes coverage available to them. For workers to access ESI, they need to work for an employer that offers ESI and be eligible to enroll in coverage offered at their job. About 4 in 5 (80.4%) adult workers under age 65 worked for an employer that offered ESI to at least some employees as of March 2025. Most (92.8%) of these workers were eligible for the ESI offered at their job. Overall, in 2025, about 3 in 4 of all workers were eligible to enroll in the ESI offered at their job.

Among workers ages 18-64 years, share working for an  offering employer and share eligible for employer-sponsored health insurance (ESI) at job, overall and by poverty level, March 2025 (Grouped Bars)

Both the share of workers working for employers offering coverage and the share of workers eligible for coverage at their jobs vary significantly with income. Among adult workers under age 65, the share working for an employer offering ESI ranged from 60.4% for workers with incomes under 200% of the FPL to 87.5% for workers with incomes at least 400% of the FPL. Similarly, the share eligible for coverage ranged from 48.9% for workers with incomes under 200% of the FPL to 83.4% for workers with incomes of at least 400% of the FPL.

Both working for an offering employer and being eligible for the offered coverage are dependent on a combination of characteristics. As of March of 2025, workers under age 65 working in construction, service, sales, and farm, fishing and forestry-related occupations were less likely to be working for an employer offering ESI and to be eligible for ESI at their jobs. Full-time workers were much more likely to be working for an employer offering ESI and to qualify for coverage at their job. There also was significant variation in offer rates and eligibility within sex, age group, race and ethnicity, and citizenship.

Among workers ages 18-64 years, share working for an offering employer and share eligible for employer-sponsored health insurance (ESI) at job, By occupation and full-time/part-time status, March 2025 (Grouped Bars)

How Many Workers Take Employer-Sponsored Health Insurance Available at Their Job?

Copy link to How Many Workers Take Employer-Sponsored Health Insurance Available at Their Job?
Among workers ages 18-64 years eligible for employer-sponsored health insurance (ESI) at work, share covered from own job or other sources, March 2025 (Bar Chart)

Among adult workers under age 65 eligible for ESI at their jobs in March 2025, 75.5% were ESI policyholders. Of those who did not have ESI from their own job, 13.6% were covered by ESI as a dependent, 3.9% had Medicaid or other public coverage, 2.2% had non-group coverage, 1.1% had some other coverage, and 4.1% were uninsured. A small share of workers with ESI from their job also had other coverage at the same time: 2.2% also had Medicaid or other public coverage and 0.7% also had non-group coverage.

What Share of Employers Offer Health Benefits to Their Workers?

Copy link to What Share of Employers Offer Health Benefits to Their Workers?
Percentage of Firms Offering Health Benefits, by Firm Size, 1999-2025 (Line chart)

Among firms with 10 or more workers, over half (61%) offered health benefits to at least some of their workers in 2025. Firm offer rates differed significantly with firm size. Only 51% of firms with 10 to 24 workers offered health benefits, while virtually all (97%) firms with at least 200 employees did so. While a majority of firms are small, 61% of firms with 10 or more employees have fewer than 25 employees; these firms employ just 10% of workers. Sixty-nine percent of workers work for firms with 200 or more employees, where the employer offer rate is almost 100%.

Among firms offering health benefits, 18% of firms with fewer than 200 workers and 27% of larger firms offered health benefits to part-time workers in 2025.

Ninety-six percent of firms offering health benefits offered them to dependents (e.g., spouses and children) of their workers in 2025.

What Are the Premiums for Employer-Sponsored Health Insurance?

Copy link to What Are the Premiums for Employer-Sponsored Health Insurance?
Average Annual Worker and Employer Premium Contributions for Family Coverage, 2015, 2020 and 2025 (Stacked column chart)

Employer health insurance premiums are the total of what employers and employees pay to providers for health coverage through employment. Generally, premiums are the estimated cost of health spending for the covered population, as well as the administrative costs and fees associated with the plan. Therefore, premiums usually increase when a covered population either uses more health services or the prices for health care increase. In 2025, the average total premiums for covered workers were $9,325 for single coverage and $26,993 for family coverage (for a family of four). Employer contributions to an employee’s health insurance premium are a sizeable share of an employee’s overall compensation (6.9% for private industry as of June 2025).

Premiums varied around these averages due to factors such as the age and the health of the workforce, the cost of the providers included in the network, and the generosity of the coverage. In 2025, 23% of covered workers worked at a firm with an average annual premium of at least $31,500 for family coverage. The robustness of plan offerings varies across firms, with some employers offering generous benefits to attract new employees, while others prioritize more affordable plan options. Some employers sponsor limited-benefit plans, which may cover a limited number of services but have lower costs. The average family premium for covered workers at firms with a relatively large share of lower-wage workers (firms where at least 35% of the workers earn $31,000 annually or less) is lower than at firms with fewer lower-wage workers. On the other hand, the average premiums for single and family coverage are relatively higher in the Northeast and in private not-for-profit firms. There is additional discussion of how premiums vary with firm characteristics here.

During the late 1990s and early 2000s, health insurance premiums grew at a rate considerably faster than inflation and workers’ wages. Recently, the rate of growth has moderated. For example, over the last five years, family premiums have grown 26%, roughly comparable to the rate of inflation (23.5%) and the change in wages (28.6%). When faced with higher premium costs, employers can adjust their plan offerings, increase cost sharing, drop high-cost providers, or change how benefits are covered in other ways.

How Much Do Workers Contribute Towards the Premiums for Employer-Sponsored Health Insurance?

Copy link to How Much Do Workers Contribute Towards the Premiums for Employer-Sponsored Health Insurance?

Workers contribute to health insurance in two ways. First, through a premium contribution, which is typically deducted from an employee’s paycheck. Then, secondly, through cost-sharing such as copays, coinsurance, and/or deductibles, which are paid when the employee utilizes services covered by their plan. While all workers enrolled in the plan must pay their premium (or have it paid by the employer), overall cost sharing is higher for workers who use more services.

Workers with health coverage in 2025, on average, were responsible for 16% of the premium for single coverage and 26% of the premium for family coverage. In dollar terms, the average annual contribution for covered workers was $1,440 for single coverage and $6,850 for family coverage.

Over time, the average premium contribution for covered workers has increased. For example, over the last 10 years, the single coverage average contribution has increased 31% and the family coverage average contribution increased 37%. At the same time, the share of the premium paid by workers has remained relatively consistent. In 2025, covered workers contributed, on average, 16% of the premium for single coverage and 26% of the premium for family coverage, which was similar to these averages a decade ago. This is because as premiums have increased over time, both employers and employees have faced similar increases on average.

There remains a lot of variation in how much workers are required to contribute to their health plan across firms, particularly within firm size. In 2025, 29% of covered workers at small firms were enrolled in a plan where the employer paid the entire premium for single coverage. This was only the case for 7% of covered workers at large firms. However, 29% of covered workers at small firms were in a plan where they must contribute more than half of the premium for family coverage, compared to 5% of covered workers at large firms. The family average contribution rate for covered workers in firms with fewer than 200 employees was 36%, which is higher than the average contribution rate of 23% for covered workers in larger firms. Small firms often approach the cost of health insurance differently than large firms, sometimes making the same employer contribution regardless of whether the employee enrolls any dependents. Similarly, some large employers encourage spouses and dependents to enroll in other plans, if they have access, through spousal surcharges.

Distribution of Percentage of Premium Paid by Covered Workers for Single and Family Coverage, by Firm Size, 2025 (Stacked Bars)

In addition to any required premium contributions, most covered workers must pay a share of the cost of the medical services they use. The most common forms of cost-sharing are deductibles (an amount that must be paid before most services are covered by the plan), copayments (fixed dollar amounts), and coinsurance (a percentage of the charge for services). Some plans combine cost-sharing forms, such as requiring coinsurance for a service up to a maximum amount or requiring either coinsurance or a copayment for a service, whichever is higher. The type and level of cost sharing may vary with the kind of plan in which the worker is enrolled. Cost sharing may also vary by the type of service, with separate classifications for office visits, hospitalizations, and prescription drugs. Plans often structure their cost sharing to encourage enrollees to reflect on their use, reducing overall utilization.

Among Covered Workers Who Face a Deductible for Single Coverage, Average General Annual Deductible for Single Coverage, by Firm Size, 2006-2025 (Line chart)

In recent years, general annual deductibles have grown in prominence in plan design. In 2025, 88% percent of covered workers were enrolled in a health plan which required that an enrollee met a deductible before the plan covered most services. As of 2025, the average deductible amount for workers with single coverage and a general annual deductible was $1,886. On average, covered workers at smaller firms face higher deductibles than those at large firms ($2,631 vs. $1,670). Generally, a substantial share of workers faced relatively high deductibles. Fifty-three percent of workers at small firms and 28% of workers at large firms had a general annual deductible of $2,000 or more. Over the last five years, the percentage of covered workers with a general annual deductible of $2,000 or more for single coverage has grown from 26% to 34%.

While average deductibles have not grown over the last few years, the growth over the last 10 years outpaces the increases in premiums, wages and inflation. The rise in deductible costs has focused attention on consumerism in health care. Some believe that increasing deductibles will place a greater incentive on enrollees to shop for services, therefore reducing total plan spending. Alternatively, deductibles are less common in Health Maintenance Organization (HMO) plans, which use forms of gatekeeping to dissuade utilization. The growth of deductibles has had important consequences for the financial protection that health insurance provides. A multitude of plans require deductibles well in excess of the financial assets of many of their enrollees. As opposed to coinsurances and copays that accumulate throughout the year, deductible spending may require enrollees to finance relatively high expenses all at once.

Cumulative Increases in Family Coverage Premiums, General Annual Deductibles, Inflation, and Workers' Earnings, 2015-2025 (Line chart)

In addition to looking at the average obligations enrollees face under their health plan, we can look at the actual spending incurred by enrollees in large group plans. In 2021, deductibles accounted for more than 58% of an enrollee’s cost-sharing liability, which is significantly greater than 35% of enrollee liability 10 years prior.

The amount of cost sharing large group enrollees face varies, particularly around how many health services a person uses. Individuals who have a hospitalization, or a chronic condition that requires ongoing management, often incur higher cost-sharing over the year. For example, large group enrollees faced an average of $779 in cost sharing, but individuals with a diabetes diagnosis (even without complications) incurred costs of $1,585 in 2017.

Distribution of out-of-pocket spending for people with large employer coverage, 2003-2021 (Stacked Bars)

While some employer health plans have relatively generous benefits, there remains a concern about affordability, particularly for lower-wage workers who do not have the assets to meet the cost-sharing required under their plan, as well as for individuals enrolling in family coverage at smaller firms. Overall, individuals in families with employer coverage spend 2.4% of their income on the worker contribution required to enroll in an employer-sponsored health plan, and another 1.4% of their income on typical out-of-pocket spending on cost-sharing. Individuals covered by employer-sponsored plans in households at or below 199% of the FPL contribute 9.6% of their income on average towards their premiums and cost-sharing.

A key component of plan design is the out-of-pocket maximum, which caps the amount of money an enrollee spends on in-network covered benefits within a year.

The ACA requires that almost all plans have an out-of-pocket (OOP) maximum below a federally determined limit. In 2025, 12% of covered workers in plans with an OOP maximum had an OOP maximum of less than $2,000 for single coverage, while 21% of these workers had an OOP maximum above $6,000.

What Types of Employer-Sponsored Health Insurance Plans Do Workers Have?

Copy link to What Types of Employer-Sponsored Health Insurance Plans Do Workers Have?

Today virtually all plans have preferential cost sharing for enrollees to visit providers participating in a preferred provider network. Some plans require enrollees to visit a primary care physician or other gatekeeper before they are referred to a specialist. Plans are often categorized based on these characteristics. 

Preferred Provider Organization (PPO)

PPO plans are the most common plan type. These plans typically have broader provider networks and do not require gatekeeping for specialist services. However, insurers may still use utilization management tools, such as prior authorization, to determine appropriate use and which services will be paid for under the plan. Point-of-service (POS) plans have a provider network like a PPO plan but require gatekeeping for referrals. POS plans are more common in the Northeast and among smaller firms. 

Health Maintenance Organization (HMO)

HMO plans represented 12% of covered workers in 2025. HMO enrollment has decreased over the past few decades, compared to nearly 3 in 10 workers who were enrolled in HMOs in the late 1990s. HMOs do not cover non-emergency out-of-network services, and some integrate health care financing and services delivery. Since providers in these plans are not paid on a fee-for-service basis, they are designed to encourage lower utilization to reduce costs.

High Deductible Health Plan with a Savings Option (HDHP-SO)

HDHP-SO is a relatively new plan type. This plan pairs a high deductible with either a Health Reimbursement Arrangement (HRA) or Health Savings Account (HSA). HSA-qualified plans were first authorized in the Medicare Modernization Act of 2003 and grew precipitously until 2015. HDHP-SO plans now represent almost 3 in 10 covered workers, including almost a quarter enrolled in an HSA-qualified plan. These plans may be an HMO, PPO, or POS, meeting specified federal guidelines. HSA-qualified plans allow both employers and enrollees to contribute to a tax-preferred savings account, which enrollees can use to meet their cost-sharing requirements or save for future health spending. On average, HSA-qualified health plans have higher deductibles than other plan types and lower premiums. The growing enrollment in HSA-qualified plans has led to a growth in general annual deductibles overall. While having a higher deductible in other plan types generally increases enrollee out-of-pocket liability, this is not necessarily true for HDHP-SO plans. Many HDHP-SO enrollees receive an account contribution from their employers, reducing the higher cost-sharing in these plans. In 2025, 62% of employers offering single coverage and 61% of employers offering family coverage, as well as an HSA-qualified health plan, contributed to the enrollee’s account. On average, employers contributed $690 to single coverage HSA-qualified HDHPs and $1,296 to family coverage HSA-qualified HDHPs. Some employers may make their account contribution contingent on other factors, such as completing wellness programs

Distribution of Health Plan Enrollment for Covered Workers, by Plan Type, 1988-2025 (Stacked Bars)
Average Annual Premiums and Contributions for Covered Workers in HDHP/SOs and Non-HDHP/SOs, for Family Coverage, 2025 (Stacked column chart)

What Types of Network Strategies Do Employer-Sponsored Health Insurance Plans Use?

Copy link to What Types of Network Strategies Do Employer-Sponsored Health Insurance Plans Use?

Employer plans typically include provider networks, in which enrollees face lower out-of-pocket expenses if they receive care from a designated provider. Firms and health plans structure their networks of providers to ensure access to care to encourage enrollees to use providers who are lower cost or who provide better care. Employees generally prefer broad network plans, and job-based plans are typically broader than those offered on the Marketplaces. Even so, some employers offer a health plan with a relatively small network of providers. These narrow network plans limit the number of providers that can participate to reduce costs and are more restrictive than standard HMO networks. In 2025, 9% percent of firms offering health benefits reported that they offer at least one narrow network plan to their employees.

More frequently, firms use tiered or high-performance networks in which providers are selected and then grouped within the network based on the quality, cost, and/or efficiency of care they deliver. Enrollees then receive lower cost sharing by choosing a provider in a lower tier.

Another way plans designate preferred providers is through “Centers of Excellence”, which are facilities or providers that health plans and employers single out as suppliers of exceptionally high-value specialty care for specific conditions. Plans and employers may encourage or require enrollees to use these designated providers to receive coverage for certain types of care.

As major purchasers of health care, many view employers as having considerable leverage in health care markets based on their network design. This leverage is dampened by a combination of factors, including the prevalence of highly concentrated provider markets, employees’ preferences for broad network plans, and the challenges of building networks capable of delivering timely access.

One specific concern is the availability of mental health providers. Most firms (92%) reported that they believed their largest plan offered timely access to primary care providers. However, only 70% of firms believed there were enough mental health providers in their largest plan’s network to provide timely access to services. As plan costs continue to rise for employers, these networks may be further limited as high-cost providers are removed to mitigate costs.

One policy intended to promote employers’ ability to construct lower-cost networks is the new price transparency rules, which require hospitals and health plans to disclose the prices for services. Employers may use this information to identify high-cost providers or if providers charge lower prices to other payers. This could lead to more active shopping or the development of networks that encourage the use of lower-priced providers. However, even with this additional price information, employers may still face constraints in how they design their networks, particularly in highly consolidated provider markets or in areas where maintaining adequate access remains a concern.

Additional Strategies to Improve Health and Control Cost

Copy link to Additional Strategies to Improve Health and Control Cost

In addition to cost-sharing requirements and network design, many employers use other strategies to influence both the health of their workforce and the cost of their health plans.

One such strategy is utilization management, where insurers evaluate enrollees’ health care use. A common tool is prior authorization, where an insurer reviews the appropriateness of certain services or prescriptions before covering them. Plans may use prior authorization to limit the use of services they believe are often used inappropriately or to encourage lower-cost alternatives. In recent years, prior authorization has come under public scrutiny for delaying care and adding complexity for patients. Among large employers (those with 200 or more workers), 12% believe their employees have a high level of concern about the complexity of prior authorization requirements, and another 32% believe employees’ concern is moderate. In early 2025, many insurers pledged to voluntarily expedite their prior authorization processes and improve enrollee communication. How these changes will affect enrollees’ access to timely care remains to be seen, or if ultimately prior authorization becomes the target of new legislation.  While loosening restrictions could improve access, it may also lead to higher plan costs and premiums if more services are used.

Another approach is to promote population health in order to improve the health and productivity of workers and their family members while also potentially reducing health care spending. Many employers try to achieve this through wellness programs, which may include initiatives such as exercise programs, health education classes, health coaching, and stress management counseling. Among large firms offering health benefits, 68% offer programs to help employees stop smoking or using tobacco, 63% offer programs to support weight loss, and 74% offer other forms of lifestyle or behavioral coaching. Overall, 83% of large firms offer at least one of these programs. Some wellness programs are tied to financial incentives or penalties, which can increase costs for enrollees who choose not to participate in wellness activities, decline health screenings, or, in some cases, fail to meet biometric targets.

Future Outlook

Copy link to Future Outlook

While ESI seems likely to remain the dominant source of health insurance for working families, employers and working families each face challenges relating to affordability and access to care. These include: 

Ultimately, health care is expensive, and the cost of good ESI coverage can place a strain on employers and employees, particularly for workers with lower wages. Additionally, only about half of workers with incomes below 200% of the FPL are even eligible for ESI at their workplace. Can ESI be a source of affordable coverage for all working families, or are novel approaches to providing affordable coverage options needed for these families? 

Many ESI policies have significant deductibles and other out-of-pocket costs to keep the premium costs down, while increasing the cost of obtaining care for enrollees. Can and will employers continue to increase out-of-pocket costs, and, if not, how will they control the costs of ESI going forward? 

What avenues are available to employers to increase access to care for people with mental health and substance use care needs? Is telehealth a sufficient response? 

Can employers and health plans develop provider networks that provide quality health care at lower costs? 

Resources

Copy link to Resources

2025 Employer Health Benefits Survey 

2025 Employer Health Benefits Chart Pack 

Long-Term Trends in Employer-Based Coverage - Peterson-KFF Health System Tracker 

Long-Term Trends in Employer-Based Coverage 

Many Workers, Particularly at Small Firms, Face High Premiums to Enroll in Family Coverage, Leaving Many in the ‘Family Glitch’ 

How many people have enough money to afford private insurance cost sharing? 

The burden of medical debt in the United States 

How affordability of employer coverage varies by family income 

Increases in cost-sharing payments continue to outpace wage growth 

What do we know about people with high out-of-pocket health spending? 

Preventive services use among people with private insurance coverage 

Many Workers, Particularly at Small Firms, Face High Premiums to Enroll in Family Coverage, Leaving Many in the ‘Family Glitch’ 

Out-of-pocket spending on insulin among people with private insurance 

Employer Responsibility Under the Affordable Care Act 

Citation

Copy link to Citation

Claxton, G., Rae, M., & Winger, A., Employer-Sponsored Health Insurance 101. In Altman, Drew (Editor), Health Policy 101, (KFF, April 2026) https://www.kff.org/health-policy-101-employer-sponsored-health-insurance/ (date accessed).

The Business of Health with Chip Kahn

Podcast Trailer:
KFF’s The Business of Health 

April 15, 2026

Video

Audio

About this Episode


In advance of the launch of KFF’s new podcast, “The Business of Health with Chip Kahn,” the host, KFF’s Senior Visiting Fellow Chip Kahn, explains that for the caring to work in health care, the business of health care has to work and deliver for the patients who depend on it. “This podcast is about that business,” Kahn explains.

The Host


Headshot photo of Chip Kahn wearing a navy blue suit with a red tie, red pendant on lapel, and glasses.

Sr. Visiting Fellow

Charles N. Kahn III is a senior visiting fellow at KFF. He is also a visiting senior fellow at the American Enterprise Institute (AEI) and a nonresident senior scholar at the University of Southern California’s Schaeffer Center for Health Policy & Economics. He serves as co-chair of the international Future of Health collaborative.


SERIES

This weekly podcast features insightful conversations between host Chip Kahn and his guests, who discuss the business of health care, connecting the dots between the health care business, policy, and patients.

The podcast’s first series on AI in health care illuminates how AI is changing health care, and features guests who are deploying this technology, managing its consequences, and designing policy around it.

Implementing Medicaid Work Requirements: Lessons from Unwinding

Published: Apr 14, 2026

The 2025 reconciliation law requires states to condition Medicaid eligibility for adults in the Affordable Care Act (ACA) Medicaid expansion group and enrollees in partial expansion waiver programs (Georgia and Wisconsin) on meeting work requirements starting January 1, 2027, with the option for states to implement requirements earlier. To implement Medicaid work requirements, states will need to make policy and operational decisions, develop new outreach and education strategies, implement system upgrades or changes, and hire and train staff, all within a relatively short timeframe. 

As states begin the process of implementing new Medicaid work requirements, they may draw on lessons from their recent experience with “Medicaid unwinding.” In April 2023, states began the process of unwinding the Medicaid continuous enrollment provision, a pandemic-era policy that generally stopped disenrollment in return for extra federal funds provided to states. During the unwinding, states conducted eligibility redeterminations for everyone on the program and disenrolled those who were no longer eligible or who did not complete the renewal process.

State experience with Medicaid unwinding illustrated the complexity of Medicaid eligibility processes and that outcomes reflect federal and state policy decisions, implementation and systems. KFF interviews with state officials, managed care plans, primary care associations, and advocacy organizations involved with the Medicaid unwinding in 2023, as well as interviews from the 23rd annual budget survey of Medicaid officials, provided lessons about outreach and engagement and renewal processes. This brief highlights lessons from unwinding that could help inform work requirement implementation. Key takeaways include:

  • Successful outreach and communication generally utilize an array of strategies and partnerships to reach and educate enrollees about changes to the program. Managed care organizations (MCOs) can help identify enrollees and provide outreach.
  • Streamlined renewal processes and increases to ex parte, or automated, renewals help to maintain enrollment for those eligible and reduce state burdens; however, implementing multiple policy changes in tight timeframes can result in significant challenges for systems and staff.
  • While states can draw on their experiences from the Medicaid unwinding, they will face new challenges unique to implementing work requirements. These include the need to collect and incorporate new information when making eligibility determinations, conduct targeted rather than broad outreach, and implement complicated system changes and integrate new data, as well as the inability to replicate certain flexibilities that were available during unwinding.

What lessons from unwinding could inform implementation of work requirements?

Successful outreach and communication generally utilize an array of strategies to reach and educate enrollees about changes to the program. During unwinding, many states expanded the number of touchpoints before renewal and engaged in multi-modal communication strategies. These included broad efforts (e.g., traditional communication campaigns, paid advertising, press conferences, and toolkits for partner organizations), direct outreach to enrollees (e.g., mailers and text messaging), and targeted outreach to certain populations such as people with limited English proficiency. States also used new strategies to update contact information, such as using the National Change of Address database and accepting updated contact information from managed care organizations (MCOs), with reductions in returned mail. Groups reported that finding the correct balance of frequency of outreach and ensuring clear messaging is key to not overwhelm or confuse enrollees.

Partnerships can amplify outreach and provide feedback loops. During the Medicaid unwinding, most states worked with a wide range of groups to reach Medicaid enrollees, including managed care organizations (MCOs), providers (such as community health centers, other primary care providers, and pharmacies), community-based organizations, navigator/assister organizations, and faith-based groups to amplify state outreach efforts. State officials and groups working directly with affected enrollees found local marketing and word of mouth to be effective methods for reaching enrollees. Many states also held regular meetings to provide updates and review data with others involved in unwinding. Feedback loops with community partners helped identify early problems; conversely, limited state engagement and communication contributed to frustration and more reports of problems.

Managed care organizations (MCOs) can help identify enrollees and provide outreach. During unwinding, some MCOs were able to take on new roles with enrollees as a result of certain waivers and flexibilities (post-unwinding, states have the option to permanently adopt many renewal strategies). State officials and managed care representatives reported that MCOs providing direct outreach to enrollees and sharing updated contact information for enrollees with the state were both helpful. Other innovative approaches MCOs took included virtual renewal training events and coordination between MCOs and primary care providers so providers could work with individuals due for renewal.

Implementing multiple policy changes in tight timeframes can result in significant challenges for systems and staff. A number of states reported that their systems were old or difficult to use and not set up to produce real-time analytics. Respondents also cited staffing shortages as an ongoing challenge contributing to slower processing of renewals and backlogs. Several mentioned that their staff was not experienced enough to handle the large workload, mostly due to high turnover among eligibility workers. States mentioned taking steps to increase ex parte renewal rates to reduce the burden on eligibility staff and enrollees and providing additional staff training. Leading up to the implementation of Medicaid work requirements, states have reported workforce challenges, including the need to hire or reallocate staff in anticipation of increased workloads and the need for additional staff training.

Streamlined renewal processes and increases to ex parte, or automated, renewals help to maintain enrollment for those eligible and reduce state burdens. Heading into unwinding, two-thirds of states reported taking steps to improve the share of renewals processed on an ex parte basis, such as by improving system programming rules or expanding data sources. The ability to perform ex parte renewals varied by state system. Some were able to add data sources and prioritize automating eligibility processes more easily, which in turn reduced the burden on staff.

States reported both benefits and drawbacks to having Medicaid eligibility systems that are integrated with other benefit programs. Integrated eligibility systems allow people to apply for and renew coverage for multiple benefit programs at once. States with Medicaid eligibility systems that were integrated with the Children’s Health Insurance Program (CHIP) and social benefit programs like the Supplemental Nutrition Access Program (SNAP) and the Temporary Assistance for Needy Families (TANF) program reported that data sharing across programs helped improve ex parte renewal rates and simplify renewal processes. State officials also reported that it can be more challenging to make changes to integrated systems because of the need to reconcile complex eligibility rules across programs. Waivers allowing use of SNAP data to renew Medicaid were helpful during unwinding and using SNAP data may be helpful in assessing if individuals meet work or exemption criteria for new requirements. 

How will implementing work requirements differ from unwinding experiences?

New work requirements represent a major change to Medicaid eligibility policy and will require states to collect and incorporate new information when determining eligibility. While the volume of renewals posed challenging for states during unwinding, there was no change to enrollee eligibility policy. New work requirements will affect both existing enrollees and new applicants, and will require collecting new information to verify compliance or exemption status. For example, states will likely need to add new questions to Medicaid applications and renewal forms, as well as incorporate new data sources (see more below). States will also have to train staff on new eligibility policy and verification requirements. Instead of doing traditional point-in-time determinations, states will have to consider historical information and confirm that an individual was meeting requirements in one or more months prior to application. 

While states can draw on their experiences conducting outreach during the Medicaid unwinding, educating enrollees about work requirements may pose unique challenges. While unwinding affected the entire Medicaid population, work requirements affects only a subset of Medicaid adult expansion enrollees. Compared to the broad outreach conducted during unwinding, states will need to provide more targeted outreach to reduce confusion among Medicaid enrollees and applicants who are not affected by the new work requirements. For those who are affected, states will need to educate individuals on the new requirements, the list of exemptions, how to document compliance, and how to know that you need to submit information. States will likely want to work with a narrower subset of community partners than during unwinding that primarily work with or serve Medicaid expansion adults.

Some flexibilities made available during unwinding will not be helpful for verifying compliance with work requirements. CMS encouraged states to adopt a range of waivers and flexibilities to increase ex parte rates and streamline renewals during unwinding. States reported that streamlining renewals for those with zero and low income were among the most helpful waivers. However, these waivers will be less helpful going forward since determining compliance with work requirements may require income documentation and exemptions will not be based on income. Some states also received waivers that allowed MCOs to help their members complete renewals. The new federal reconciliation law prohibits MCOs from being able to determine beneficiary compliance, but states may be able to engage with MCOs to assist with identification and outreach to enrollees and assist members with completing renewals when implementing work requirements.

Implementing work requirements may require more complicated system changes than states experienced during unwinding, due to the need to integrate various data from agencies and external sources. While states will be able to build on system improvements made during unwinding, implementing work requirements will require more varied data to automate verification of exemptions and qualifying activities, such as meeting minimum education hours or participating in substance use disorder treatment. States may need to identify and establish linkages with new sources, such as gig work platforms, student databases, and claims data to increase the share of applicants and enrollees who can be automatically determined to meet the requirements. In addition, when implementing work requirements, states will have to simultaneously implement other forthcoming changes such as changes to eligibility renewal frequency for expansion adults and changes to retroactive eligibility. States also needed to complete work requirement changes for SNAP that went into effect at the end of 2025, which may have delayed the initiation of work on the Medicaid changes for states with integrated Medicaid and SNAP eligibility systems.

Domestic HIV Funding in the White House FY2027 Budget Request

Author: Lindsey Dawson
Published: Apr 10, 2026

President Trump’s FY 2027 budget request, the second of his second term, was released on April 3, 2026, and proposes significantly reduced funding for some domestic HIV programs. A budget request lays out presidential administration priorities both in terms of policy issues and the level of funding requested (or proposed for elimination). Congress then considers the request but ultimately has “the power of the purse” and is responsible for appropriating funding for discretionary programs. Those appropriations can, and often do, differ from levels proposed by the administration. Indeed, while President Trump also called for reduced HIV funding in his budget request for FY 2026, Congress appropriated funding similar to prior year levels.

Beyond the traditional budget process, the Trump administration has taken several executive actions to terminate or limit already appropriated funding by delaying or cancelling funding, including for accounts and grants related to HIV. In some cases these actions have led to litigation, sometimes resulting in grants being reinstated. In addition, the administration has used the recission process, whereby the president asks Congress to rescind appropriated funds, which reduces funding if approved by Congress, though to date, recissions have not impacted domestic HIV accounts. These administrative actions have led to uncertainty regarding availability of federal dollars, including for HIV programs, grantees, and sub-grantees, even after funds are appropriated.

The FY 2027 request for domestic HIV, like the FY 2026 request, calls for the elimination or transformation of several core programs, while maintaining others. As with the FY 2026 request, proposals to bolster PrEP uptake that had become a feature of Biden Administration HIV requests, were not included. Funding for the Ending the HIV Epidemic Initiative, an effort born during the first Trump Administration, has been maintained. While detailed funding information is not available for all accounts, where levels are known, the FY 2027 budget request for domestic HIV programs represents a $1.6 billion (35%) decline compared to final FY 2026 funding levels.   

If these cuts are enacted, it could make addressing HIV more challenging at a time when other changes to the health policy landscape could negatively impact access to HIV care and prevention services.

A summary of the request for domestic HIV programs is below.

Overview

The request includes discretionary funding for key programs aimed at addressing the domestic HIV epidemic, including for the Ryan White HIV/AIDS and Health Center Programs, programs that the budget moves from the Health Resources and Services Administration (HRSA) to the proposed new agency, the Administration for Healthy America (AHA). Congress rejected the FY26 request’s proposal to create and fund AHA during the appropriations process. The FY27 request states that AHA will prioritize HIV/AIDS programs (among other areas), “aligning with the Administration’s priorities”. Other funding that has been provided to other departments/agencies for HIV activities is also moved to AHA. This includes funding for the Office of Infectious Disease and HIV/AIDS Policy (OIDP) for HIV and other infectious disease related activities, as well as all EHE funding previously allocated to Centers for Diseases Control and Prevention (CDC).

At the same time, the request eliminates a range of historical HIV programs including funding for domestic HIV prevention at the CDC, Part F of the Ryan White HIV/AIDS Program, and at least some parts of the Minority AIDS Initiative (MAI). Additionally, large cuts are proposed for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health, which has been the largest source of HIV research funding in the world. The request also proposed cutting the Housing Opportunities for People with AIDS (HOPWA) program which is a program of Department of Housing and Urban Development.

Specific, known funding levels are as follows:

Centers for Disease Control and Prevention (CDC)- Domestic HIV Prevention

Funding for core HIV prevention programs at the CDC is eliminated in the budget request and only funding previously provided to the CDC for EHE activities ($220 million) is preserved but moved to AHA. Historically, CDC has accounted for almost all (91%) federal funding for domestic HIV prevention. This cut would represent a $794 million decrease (78%) over the FY26 level ($1 billion, including the EHE) for HIV funding, but a total elimination of funding for the division.

While CDC’s HIV prevention funds are eliminated in the proposal, some funding for infectious diseases has been retained and combined into one account. Previously, CDC funding for viral hepatitis, sexually transmitted infections, and tuberculosis prevention had separate funding lines. The request proposes to group those accounts into a single $300 million line. The $300 million funding level is $70 million below the sum of these individual accounts in FY 2026.

These changes at CDC were also proposed in the FY26 budget request but rejected by Congress.

Ryan White HIV/AIDS Program

The Ryan White HIV/AIDS Program, the nation’s safety-net for HIV care and treatment (now housed at HRSA, and would be moved to AHA), receives $2.5 billion in the FY 2026 request, a $74 million (3%) decrease over the FY 2026 enacted level. The request includes $165 million for EHE activities within Ryan White, the same as in FY 2026. The overall program decrease of $74 million is attributed to the elimination of funding for Part F of the program which has included the following components:

  • AIDS Education and Training Centers (AETCs) whichprovide education and training for health care providers who treat people with HIV.
  • Dental Programs: The “Dental Reimbursement Program” reimburses dental schools and providers for oral health services. The “Community-Based Dental Partnership Program” supports dental provider education and expands access to oral care for people with HIV. 
  • Minority AIDS Initiative (MAI): Created in 1998 to address the impact of HIV on racial and ethnic minorities, MAI provides funding to strengthen organizational capacity and expand HIV services in minority communities. (See additional discussion of MAI below.)

Community Health Center HIV Funding

The FY 2027 budget request includes $157 million in HIV funding for the Health Center Program (now housed at HRSA and would be moved to AHA), all of which is for the EHE initiative; the same amount as the FY 2026 level. EHE funding in health centers “support efforts to reduce new HIV infections through outreach, routine and risk-based testing, and increased access to Pre-Exposure Prophylaxis for patient.”

Office of Infectious Disease and HIV/AIDS Policy (OIDP)

The FY27 budget provides $7.6 million in funding to the Office of Infectious Disease and HIV/AIDS Policy (OIDP) (now housed at the Office of the Assistant Secretary of Health, it would be moved to AHA). OIDP plays a coordinating role, including historically for EHE effort and national HIV, STI, and hepatitis strategies. Funding for OIDP is provided in the request to “drive progress [in] MAHA priorities by implementing innovative, evidence-based interventions to prevent, diagnose, and treat HIV/AIDS, STIs, viral hepatitis, nosocomial infections/hospital – acquired infections (HAIs), and antibiotic-resistant organisms.” It also supports OIDP to “coordinate national strategies, support data-driven program development, and engage communities most affected by these conditions.”

National Institutes of Health – Domestic HIV Research

Historically, the National Institutes of Health (NIH) has carried out almost all federally funded HIV research activities. The budget proposes significant cuts to NIH overall, including to the National Institute of Allergy and Infectious Disease (NIAID) which would be cut by $1.8 billion (27%), from approximately $6.5. billion to $4.8 billion. While the amount of funding for domestic HIV research at NIH is not yet known, in FY 2025, it was $3.3 billion (amount provided to KFF via data request). The Office of AIDS Research, which sits in the Office of the NIH Director and plays a coordinating role withing NIH is mentioned in the budget’s technical appendix, although a specific funding amount is not provided.

Indian Health Service (IHS)

In the FY27 budget, $5 million for IHS EHE activities to support ending HIV and hepatitis C in Indian Country is continued, the same as the FY26 final level. (Funding information provided to KFF via data request.)

The Minority AIDS Initiative (MAI)

As noted above, the MAI was created in 1998 to address the disparate impact of HIV on racial and ethnic minority communities and to build resources and organizational capacity within these communities. The status of the Minority AIDS Initiative is unclear. Funding that has been provided for MAI activities at the Substance Abuse and Mental Health Services Administration (SAMHSA) which the budget would move to AHA, aimed at “improving the health of people of color who have or are at risk for HIV” is eliminated in the proposal. In FY 2026 SAMHSA received $119 million for the MAI. Another $56 in MAI funding is eliminated from the Secretary’s Minority HIV/AIDS. In addition, as noted, Ryan White funding for Part F, which includes a funding line for MAI, is also eliminated in the proposal.

Housing Opportunities for Persons with AIDS (HOPWA)

The Department of Housing and Urban Development’s HOPWA Program is eliminated in the budget. In FY 2026, HOPWA was funded at $529 million. HOPWA, which was established in 1992, has provided housing assistance and supportive services to low-income people with HIV facing housing insecurity and is the only federal program centered on the housing needs of people with HIV. Its funding supports grants to localities, states, and community-based organizations.

The tables below compare federal funding levels for domestic HIV, where specified, in the FY 2027 request to the FY 2026 enacted levels. EHE funding is included in the overall table (Table 1) and in a dedicated table (Table 2).

Key Discretionary Accounts in the Domestic HIV Budget Request, FY 2027 Budget Request and FY 2026 Final (in Millions) (Table)
EHE funding in the FY27 Domestic HIV Budget Request and FY 2026 Final (in Millions) (Table)

Sources: